FILANA THERAPEUTICS, INC. (FLNA) investor relations documents from the company's IR site: 6 press releases. Read in-app with summaries. First-party data.
| Published | Type | Document |
|---|---|---|
| 2026-07-29 | Press release | Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update |
| 2026-05-07 | Press release | Filana Therapeutics Reports Q1 2026 Financial Results and Business Update |
| 2026-05-05 | Press release | Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII |
| 2026-04-15 | Press release | Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data |
| 2026-03-12 | Press release | Filana Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results |
| 2026-03-10 | Press release | Cassava Sciences Announces Name Change to Filana Therapeutics, Inc. |
FLNA overview · FLNA earnings · FLNA financials · FLNA KPIs · FLNA ownership · FLNA peers · FLNA filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.